<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Galmed Pharmaceuticals Inc.</title><link>https://investorshangout.com/Galmed-Pharmaceuticals-Inc-GLMD-91263/</link><description><![CDATA[Galmed Pharmaceuticals Inc. (GLMD)]]></description><language>en-us</language><pubDate>Thu, 03 Sep 2026 16:48:19 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/Galmed-Pharmaceuticals-Inc-GLMD-91263/" rel="self" type="application/rss+xml"/><item><title>whytestocks: $GLMD News Article - Galmed to employ OnKai&#039;s disruptive Artificial Intelligence (AI) in its Planned</title><link>https://investorshangout.com/post/view?id=6594448</link><guid>https://investorshangout.com/post/view?id=6594448</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 10 Jul 2023 15:30:53 GMT</pubDate></item><item><title>whytestocks: $GLMD News Article - Galmed Announces Issuance of New Composition of Matter Patent for Aramchol megl</title><link>https://investorshangout.com/post/view?id=6533755</link><guid>https://investorshangout.com/post/view?id=6533755</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 08 Feb 2023 13:15:45 GMT</pubDate></item><item><title>znewcar1: $GLMD 45% v1,5M c.4511 f25,2M H.55 ML.29 YL.29 BO.32 then pushed to HOD</title><link>https://investorshangout.com/post/view?id=6513790</link><guid>https://investorshangout.com/post/view?id=6513790</guid><description><![CDATA[znewcar1
]]></description><pubDate>Thu, 22 Dec 2022 01:56:51 GMT</pubDate></item><item><title>whytestocks: $GLMD News Article - Galmed Pharmaceuticals Provides Additional Positive Data from the Open Label Pa</title><link>https://investorshangout.com/post/view?id=6279507</link><guid>https://investorshangout.com/post/view?id=6279507</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 08 Nov 2021 20:40:47 GMT</pubDate></item><item><title>whytestocks: $GLMD News Article - Galmed Pharmaceuticals Announces Publication in &quot;The Journal of Autoimmunity&quot; f</title><link>https://investorshangout.com/post/view?id=6219596</link><guid>https://investorshangout.com/post/view?id=6219596</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 19 Aug 2021 19:55:47 GMT</pubDate></item><item><title>whytestocks: $GLMD News Article - Galmed Pharmaceuticals to Present New Data on Aramchol Effect on Glucose Metabo</title><link>https://investorshangout.com/post/view?id=5579744</link><guid>https://investorshangout.com/post/view?id=5579744</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 31 Oct 2019 15:30:44 GMT</pubDate></item><item><title>whytestocks: $GLMD News Article - Galmed Pharmaceuticals Initiated ARMOR, a Phase 3/4 Registrational Study of Ara</title><link>https://investorshangout.com/post/view?id=5549304</link><guid>https://investorshangout.com/post/view?id=5549304</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 26 Sep 2019 15:20:43 GMT</pubDate></item><item><title>whytestocks: $GLMD News Article - Galmed Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Resu</title><link>https://investorshangout.com/post/view?id=5378247</link><guid>https://investorshangout.com/post/view?id=5378247</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 13 Mar 2019 20:05:41 GMT</pubDate></item><item><title>znewcar1: 19% 5.3M C15.24 WL retraced 15% $10.5 two day prior then sideways the day prior. R16, then 19, 27 s</title><link>https://investorshangout.com/post/view?id=5131349</link><guid>https://investorshangout.com/post/view?id=5131349</guid><description><![CDATA[znewcar1
]]></description><pubDate>Fri, 13 Jul 2018 20:08:45 GMT</pubDate></item><item><title>PoemStone: $GLMD breakout candles at </title><link>https://investorshangout.com/post/view?id=4611876</link><guid>https://investorshangout.com/post/view?id=4611876</guid><description><![CDATA[PoemStone
]]></description><pubDate>Sat, 17 Jun 2017 23:05:04 GMT</pubDate></item></channel></rss>